ArticleEuropean journal of case reports in internal medicine2020
Deep Vein Thrombosis and Pulmonary Embolism: Two Complications of COVID-19 Pneumonia?
Article in European journal of case reports in internal medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
44 citing papers in PubMed, 1 synthesis or guideline pooled it, 69 citations in OpenAlex.
- Extrapulmonary manifestations and complications of severe acute respiratory syndrome coronavirus-2 infection: a systematic review.Singapore medical journal · 2023Pooled it
- SARS-CoV-2 Pneumonia: Advances in Diagnosis and Treatment.Microorganisms · 2025Review
- Effect of mild-to-moderate COVID‑19 on the incidence and risk factors for deep vein thrombosis in patients with hip fracture: a retrospective study.BMC surgery · 2025Article
- New trend in artificial intelligence-based assistive technology for thoracic imaging.La Radiologia medica · 2023Review
- A review of venous thromboembolism in India.The Indian journal of medical research · 2023Review
- Novel inflammatory markers in patients with severe COVID-19 and a pulmonary thrombotic event.Central-European journal of immunology · 2023Article
- A review of pathophysiological mechanism, diagnosis, and treatment of thrombosis risk associated with COVID-19 infection.International journal of cardiology. Heart & vasculature · 2022Review
- Insights into Cardiovascular Defects and Cardiac Epigenome in the Context of COVID-19.Epigenomes · 2022Review
- A comprehensive review of vascular complications in COVID-19.Journal of thrombosis and thrombolysis · 2022Review
- COVID-19 and thrombosis: The role of hemodynamics.Thrombosis research · 2022Review
- Bowel ischemia as onset of COVID-19 in otherwise asymptomatic patients with persistently negative swab.Journal of internal medicine · 2022Article
- Coagulation Disorders and Thrombosis in COVID-19 Patients and a Possible Mechanism Involving Endothelial Cells: A Review.Aging and disease · 2022Review
- The analysis of Fe-dependent serum enzymes in severe COVID-19 with a pulmonary thrombotic event.Central-European journal of immunology · 2022Article
- Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management.SN comprehensive clinical medicine · 2022Review
- Machine Learning to Calculate Heparin Dose in COVID-19 Patients with Active Cancer.Journal of clinical medicine · 2021Article
- Not all is COVID19: a case of eclampsia and posterior reversible encephalopathy syndrome in the emergency room.Acta bio-medica : Atenei Parmensis · 2021Article
- Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.Scientific reports · 2021Observational
- Clinical Differences between COVID-19 and a COVID-Like Syndrome.Journal of clinical medicine · 2021Article
- Venous thromboembolism in patients with COVID-19. A prevalent and a preventable complication of the pandemic.Journal of interventional medicine · 2021Review
- Risk and Management of Venous Thromboembolism in Patients with COVID-19.Annals of vascular surgery · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coronavirus disease 19 (COVID-19) is a worldwide infection which was recently declared a global health emergency by the WHO Emergency Committee. The most common symptoms are fever and cough, which can progress to pneumonia, acute respiratory distress syndrome (ARDS) and/or end-organ failure. Risk factors associated with ARDS and death are older age, comorbidities (e.g., hypertension, diabetes, hyperlipidaemia), neutrophilia, and organ and coagulation dysfunction. Disseminated intravascular coagulation and coagulopathy can contribute to death. Anticoagulant treatment is associated with decreased mortality in severe COVID-19 pneumonia. In this report we describe two patients with COVID-19 pneumonia who developed venous thromboembolism. LEARNING POINTS: Deep vein thrombosis and pulmonary embolism can occur in patients with COVID-19 pneumonia.Low-molecular-weight heparin prophylaxis does not decrease the risk of venous thromboembolism (VTE) in COVID-19 pneumonia.In the presence of clinical signs and/or suspicion of VTE, compression ultrasound and echocardiography should be always performed, irrespective of disease stage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.